We provide the latest news
from the world of economics and finance
(RTTNews) - Biotechnology company, Liquidia Corp. (LQDA) stock gained 9% on Thursday following announcement of a total of $100 new financings from Patient Square Capital and Healthcare Royalty.
Currently, Liquidia's shares are moving up 9.34%, to $12.41 on a volume of 1,279,314. It has traded between $5.67 and $12.51 in the past 52-week period on the Nasdaq.
The company has entered into a share purchase agreement with Patient Square Capital for private placement of around 7.2 million shares at $10.442 per share, to raise $75 million. The offering is expected to close on January 8.
The company said that it has received an additional advance of $25 million from Healthcare Royalty under their Revenue Interest Financing Agreement on Wednesday. Lululemon Founder Chip Wilson Lands In Controversy Over
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
© 2024 Lime Trading (CY) Ltd
Lime Trading (CY) Ltd is authorised and regulated by the Cyprus Securities and Exchange Commission in accordance with license No.281/15 issued on 25/09/2015. The "Just2Trade" trademark is owned by LimeTrading (CY) Ltd.
Registration Number: HE 341520
Address: Lime Trading (CY) Ltd
Magnum Business Center, Office 4B, Spyrou Kyprianou Avenue 78
Limassol 3076, Cyprus
Disclaimer:
All promotions, materials and information of this website may have applied conditions. Please contact the Company for further details
Trading on financial markets carries risks. The value of the investments can both increase and decrease and the investors may lose all their investment capital. In case of a leveraged product, the loss may be more than the initial capital invested. Detailed information on risks associated with trading on financial markets can be found in General Terms and Conditions for the Provision of Investment Services.